{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:42:36Z","timestamp":1774528956698,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 DK090181"],"award-info":[{"award-number":["R01 DK090181"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UNC Center for Pharmacoepidemiology"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1053\/j.ajkd.2015.07.026","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T08:19:52Z","timestamp":1442391592000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients"],"prefix":"10.1053","volume":"67","author":[{"given":"M. Alan","family":"Brookhart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet K.","family":"Freburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit V.","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2015.07.026_bib1","series-title":"USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","year":"2009"},{"issue":"11","key":"10.1053\/j.ajkd.2015.07.026_bib2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V12112465","article-title":"Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%","volume":"12","author":"Collins","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.07.026_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0272-6386(97)90192-X","article-title":"Iron management in end-stage renal disease","volume":"29","author":"Fishbane","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2015.07.026_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrneph.2010.139","article-title":"Iron supplementation to treat anemia in patients with chronic kidney disease","volume":"6","author":"Besarab","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.07.026_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0272-6386(99)70183-6","article-title":"Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans","volume":"33","author":"Faich","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2015.07.026_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0272-6386(01)80123-2","article-title":"Suspected iron dextran-related adverse drug events in hemodialysis patients","volume":"37","author":"Fletes","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2015.07.026_bib7","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","author":"Danielson","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2015.07.026_bib8","first-page":"S99","article-title":"Safety of intravenous iron in clinical practice: implications for anemia management protocols","volume":"15","author":"Aronoff","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2015.07.026_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1525-139X.2006.00174.x","article-title":"Intravenous iron therapy in end-stage renal disease","volume":"19","author":"Brewster","year":"2006","journal-title":"Semin Dial"},{"issue":"6","key":"10.1053\/j.ajkd.2015.07.026_bib10","doi-asserted-by":"crossref","first-page":"541.e1","DOI":"10.1016\/j.amjmed.2012.11.030","article-title":"The comparative short-term effectiveness of iron dosing and formulations in us hemodialysis patients","volume":"126","author":"Kshirsagar","year":"2012","journal-title":"Am J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2015.07.026_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1345\/aph.1P466","article-title":"A\u00a0comparative look at the safety profiles of intravenous iron products used in the hemodialysis population (February)","volume":"45","author":"Coppol","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.ajkd.2015.07.026_bib12","unstructured":"US Renal Data System. Researcher's Guide to the USRDS Database: 2010 ADR Edition. http:\/\/www.usrds.org\/2010\/rg\/A_intro_sec_1_10.pdf. Accessed September 11, 2015."},{"issue":"1","key":"10.1053\/j.ajkd.2015.07.026_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"1","key":"10.1053\/j.ajkd.2015.07.026_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1467-9868.00374","article-title":"Thin plate regression splines","volume":"65","author":"Wood","year":"2003","journal-title":"J\u00a0R Stat Soc B"},{"issue":"7","key":"10.1053\/j.ajkd.2015.07.026_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients","volume":"24","author":"Brookhart","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2015.07.026_bib16","series-title":"R: A Language and Environment for Statistical Computing [computer program]","year":"2014"},{"issue":"6","key":"10.1053\/j.ajkd.2015.07.026_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/aje\/kwp436","article-title":"Invited commentary: positivity in practice","volume":"171","author":"Westreich","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1053\/j.ajkd.2015.07.026_bib18","doi-asserted-by":"crossref","first-page":"e78930","DOI":"10.1371\/journal.pone.0078930","article-title":"Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients","volume":"8","author":"Kshirsagar","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1053\/j.ajkd.2015.07.026_bib19","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V1092029","article-title":"An indistinct balance: the safety and efficacy of parenteral iron therapy","volume":"10","author":"Besarab","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2015.07.026_bib20","first-page":"591","article-title":"Does iron cause bacterial infections in patients with end stage renal disease?","volume":"26","author":"Cieri","year":"1999","journal-title":"ANNA J"},{"issue":"4 suppl 2","key":"10.1053\/j.ajkd.2015.07.026_bib21","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0047","article-title":"Review of issues relating to iron and infection","volume":"34","author":"Fishbane","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"4 suppl 2","key":"10.1053\/j.ajkd.2015.07.026_bib22","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0030","article-title":"Iron and infection: clinical experience","volume":"34","author":"Hoen","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2015.07.026_bib23","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69125.x","article-title":"Iron and infection","volume":"69","author":"Patruta","year":"1999","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.ajkd.2015.07.026_bib24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/515549","article-title":"Iron, infections, and anemia of inflammation","volume":"25","author":"Jurado","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2015.07.026_bib25","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1345\/aph.1K187","article-title":"Risk of infection with intravenous iron therapy","volume":"41","author":"Maynor","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1053\/j.ajkd.2015.07.026_bib26","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/j.1523-1755.2004.00742.x","article-title":"Parenteral iron therapy exacerbates experimental sepsis","volume":"65","author":"Zager","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2015.07.026_bib27","first-page":"250A","article-title":"Iron dosing patterns and mortality","volume":"9","author":"Collins","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2015.07.026_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5414\/CNP66348","article-title":"Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients","volume":"66","author":"Sirken","year":"2006","journal-title":"Clin Nephrol"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2015.07.026_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2362.2002.0320s1036.x","article-title":"Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion","volume":"32","author":"Kooistra","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2015.07.026_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2362.2002.0320s1009.x","article-title":"Ferric saccharate induces oxygen radical stress and endothelial dysfunction in\u00a0vivo","volume":"32","author":"Rooyakkers","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"10.1053\/j.ajkd.2015.07.026_bib31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/ndt\/15.11.1827","article-title":"Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration","volume":"15","author":"Parkkinen","year":"2000","journal-title":"Nephrol Dial Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615010616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615010616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:43:09Z","timestamp":1759459389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638615010616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0272638615010616"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.07.026","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}